results of a phase i study of bgb-16673, a btk degrader, for r/r indolent nhl
Published 4 months ago • 149 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:35
update on phase i study of plamotamab in r/r nhl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
4:47
a study investigating the incidence of clonal hematopoiesis-related mutations in low-count mbl
-
1:13
long-term follow-up results of the phase i/ii majestec-1 trial
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
1:07
final results of a phase ii study of add-on parsaclisib for pts with mf and suboptimal rux response
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
3:32
efficacy and tolerability results from a phase i/ii study of loxo-305 in b-cell malignancies
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
3:46
overview of a phase i study of ono/gs-4059 in relapsed and refractory mature b-cell malignancies
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:55
update on the phase i/ii bruin study
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl